Séquençage d’exomes d’une cohorte de familles caucasiennes simplex dont les patients sont atteints du syndrome d’interruption de la tige hypophysaire
Pituitary stalk interruption syndrome (PSIS) is a rare disorder that affects the function of the endocrine system of the affected individuals. The absence of the pituitary stalk, assessed by MRI, characterizes patients with permanent growth hormone deficiency while the etiology of the syndrome remains unknown. PSIS is defined by clinical hypopituitarism together with anatomical findings including a hypoplastic anterior pituitary, ectopic posterior pituitary and reduced or hypoplastic pituitary stalk. We aim to find shared variations (SNP, CNV) among affected patients in coding regions which could explain the origin of the syndrome. We analyzed the exome NGS data from 8 affected French Canadian trio families, with one additional consanguineous Arabic trio family and 5 families with incomplete pedigree. These data were previously analyzed, for the same objective, by other members of the team using a standardize GATK based bioinformatics pipeline. It was desired to reanalyze the complete data set with two other independent pipelines, followed by a comparison of the SNP discovery results. In the present aspect of the study, we built two SNP discovery pipelines, both composed of a different NGS data aligners (Bowtie2) and each composed a different variant caller (Freebayes, SAMtools), then a CNV discovery pipeline which is composed of three different CNV callers (CoNIFER, fishingCNV, xHmm). In addition to the candidate mutations identified in the previous analysis, we identified additional candidate mutations which had not been detected and never been reported. Furthermore, our method helps to discover the sources of variation false discovery which could help to improve existing genomic mutation discovery pipelines.
PSIS CNV NGS GATK Bowtie2 Freebayes SAMtools CoNIFER fishingCNV xHmm GH, SNP, SNP Exome Pipeline Syndrome Rare Pituitary stalk Disorder Endocrine MRI Magnetic Resonance Growth Hormone Genomic Mutation